High-Beta Momentum in Pharmaceuticals on NASDAQ

Fair Value22.2% Upside Undervalued Analyst72.0% Upside Market Cap1.485 B P/E-98.1x Yield0.0% HealthGood

Fair Value7.5% Upside Fair Market Cap127.8 M P/E-5.2x Yield0.0% HealthFair

Fair Value-8.2% Downside Fair Analyst1.8% Upside Market Cap8.895 B P/E-17.8x Yield0.0% HealthFair

Fair Value-43.9% Downside Overvalued Analyst40.4% Upside Market Cap2.662 B P/E-58.1x Yield0.0% HealthGood

Fair Value-8.4% Downside Fair Analyst39.1% Upside Market Cap1.484 B P/E122.5x Yield0.0% HealthGreat

Fair Value31.7% Upside Undervalued Analyst21.4% Upside Market Cap80.705 M P/E4.4x Yield0.0% HealthGreat

Fair Value-21.5% Downside Overvalued Analyst110.9% Upside Market Cap176.2 M P/E-18.4x Yield0.0% HealthFair

Fair Value-1.2% Downside Fair Analyst19.2% Upside Market Cap3.365 B P/E-37.1x Yield0.0% HealthGood

Fair Value-27.1% Downside Overvalued Analyst38.8% Upside Market Cap2.018 B P/E-19.0x Yield0.0% HealthGood